American Journal of Ophthalmology
Volume 140, Issue 2 , Pages 231.e1-231.e6, August 2005

Visual Outcome and Risk Factors for Light Perception and No Light Perception Vision After Vitrectomy for Diabetic Retinopathy

  • John O. Mason III, MD

      Affiliations

    • Retina Consultants of Alabama, PC, Birmingham
    • University of Alabama at Birmingham School of Medicine, Department of Ophthalmology; Birmingham, Alabama
    • Corresponding Author InformationInquiries to John O. Mason, III, MD, Retina Consultants of Alabama, 700 South 18th Street, Suite 505, Birmingham, Alabama 35233; fax: 205-918-1319
  • ,
  • Cheri T. Colagross, DO

      Affiliations

    • Retina Consultants of Alabama, PC, Birmingham
  • ,
  • Troy Haleman, MD

      Affiliations

    • Eye Care for Kentucky; Frankfurt, Kentucky
  • ,
  • Jeffrey J. Fuller, MD

      Affiliations

    • Medical College of Georgia, Department of Ophthalmology; Augusta, Georgia.
  • ,
  • Milton F. White, MD

      Affiliations

    • Retina Consultants of Alabama, PC, Birmingham
    • University of Alabama at Birmingham School of Medicine, Department of Ophthalmology; Birmingham, Alabama
  • ,
  • Richard M. Feist, MD

      Affiliations

    • Retina Consultants of Alabama, PC, Birmingham
    • University of Alabama at Birmingham School of Medicine, Department of Ophthalmology; Birmingham, Alabama
  • ,
  • Tracy L. Emond, COT

      Affiliations

    • Retina Consultants of Alabama, PC, Birmingham
  • ,
  • Gerald McGwin Jr, PhD

      Affiliations

    • University of Alabama at Birmingham School of Medicine, Department of Ophthalmology; Birmingham, Alabama

Accepted 23 February 2005. published online 26 May 2005.

Purpose

To assess the visual outcome following vitrectomy for diabetic retinopathy compared with previous studies; to evaluate risk factors for light perception (LP) and no light perception (NLP) vision after diabetic vitrectomy.

Design

Retrospective medical record review.

Methods

The charts of 100 consecutive patients who underwent vitrectomy for proliferative diabetic retinopathy between November 1, 1997, and November 30, 1998, were reviewed. Surgical technique included standard pars plana vitrectomy with combination of delamination and segmentation of gliotic tractional membranes using bimanual techniques. All patients had post-operative follow-up of at least 12 months. Several factors were analyzed for their effect on poor visual outcome (LP and NLP) using Fisher’s exact test.

Results

Post-vitrectomy, 73% of diabetic patients had stable or improved vision; 16% had worsened but functional vision, defined as worse but still ≥ 20/400; 4% had worsened but ambulatory vision, defined as worse but still count fingers (CF) or hand motion (HM); and 7% had poor visual outcome, LP or NLP. Resultant visual acuity was ≥20/40 in 38% of patients, 20/50 to 20/100 in 34%, 20/120 to CF in 18%, HM in 3%, LP in 4%, and NLP in 3%. Risk factors for eyes with LP and NLP vision included pre-operative iris neovascularization (INV), P = .05, post-operative INV, P = .02, post-operative macular ischemia, P = .0001, and post-operative vitreous hemorrhage (VH), P = .02.

Conclusions

Pre-operative and post-operative INV, post-operative macular ischemia, and post-operative VH appear to be risk factors for LP and NLP vision following diabetic vitrectomy, whereas overall improvements in surgical technique and visual outcome continue to be reported.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Support Provided by Research to Prevent Blindness, New York, New York.

PII: S0002-9394(05)00275-8

doi:10.1016/j.ajo.2005.02.052

American Journal of Ophthalmology
Volume 140, Issue 2 , Pages 231.e1-231.e6, August 2005